Shares of Protagonist Therapeutics PTGX have gained nearly 7% over the past week. The upside came after the company announced ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...
Positive Phase 3 topline results demonstrating envudeucitinib’s leading skin clearance, meaningful symptom improvement and a favorable safety profile in patients with moderate-to-severe plaque psorias ...
Johnson & Johnson’s Icotyde receives US FDA approval for first-line systemic treatment of plaque psoriasis with a targeted oral peptide: Spring House, Pennsylvania Friday, March ...
T he recent reimbursement of Bimzelx (bimekizumab) in Ireland represents an important step forward in access to treatment for people living with immune-mediated diseases, includin ...
In a groundbreaking milestone for Bangladesh’s fintech industry, aamarPay, a leading payment system operator (PSO), has secured a foreign investment from Simpaisa, a global digital payments ...
Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...
Simpaisa has acquired aamarPay and invested nearly $1 million to expand digital payment services in Bangladesh. The investment marks a foreign fintech investment in a Payment System Operator (PSO) in ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Icotyde (icotrokinra), an interleukin-23 (IL-23) receptor antagonist for moderate-to-severe plaque psoriasis in adults and pediatric ...
Pearson (FTSE: PSON.L), the world's lifelong learning company, and Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a global leader in IT services and consulting, have announced a multi-year ...
The multi-year partnership will help enterprises build future-ready workforces by combining AI-powered learning, assessment, and cloud-led transformation at scale.LONDON and MUMBAI, March 18, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results